{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:45:18Z","timestamp":1782924318624,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.revmed.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:13:43Z","timestamp":1777612423000},"page":"248-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["French protocol for the diagnosis and management of autoimmune hemolytic anemia in adults"],"prefix":"10.1016","volume":"47","author":[{"given":"Marc","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Audia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Comont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Crickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Ebbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1800-4185","authenticated-orcid":false,"given":"Lionel","family":"Galicier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4810-1073","authenticated-orcid":false,"given":"Delphine","family":"Gobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Mahevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-3331","authenticated-orcid":false,"given":"Jean Marie","family":"Michot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ruivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6023-5990","authenticated-orcid":false,"given":"Bertrand","family":"Godeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2026.04.003_bib0310","unstructured":"Centre de r\u00e9f\u00e9rence des cytop\u00e9nies auto-immunes de l\u2019adulte (CeReCAI). Protocole national de diagnostic et de soins. An\u00e9mies h\u00e9molytiques auto-immunes de l\u2019adulte. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2024-07\/pnds_ahai_de_ladulte_version_2024.pdf."},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41572-024-00566-2","article-title":"Autoimmune haemolytic anaemias","volume":"10","author":"Michel","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.revmed.2026.04.003_bib0320","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1182\/blood-2014-06-583021","article-title":"Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients","volume":"124","author":"Barcellini","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.04.003_bib0325","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2026.04.003_bib0330","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune hemolytic anemias","volume":"385","author":"Berentsen","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.04.003_bib0335","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1002\/ajh.23767","article-title":"Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients","volume":"89","author":"Roumier","year":"2014","journal-title":"Am J Hematol"},{"issue":"20","key":"10.1016\/j.revmed.2026.04.003_bib0340","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1182\/blood-2010-03-276162","article-title":"IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independently of complement activation and FcaRI","volume":"116","author":"Chadebech","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.revmed.2026.04.003_bib0345","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/bloodadvances.2022009516","article-title":"Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review","volume":"7","author":"Jacobs","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.revmed.2026.04.003_bib0350","doi-asserted-by":"crossref","first-page":"E291","DOI":"10.1002\/ajh.26213","article-title":"Epidemiology of autoimmune hemolytic anemia: A nationwide population-based study in France","volume":"96","author":"Maquet","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0355","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/bloodadvances.2024013067","article-title":"Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study","volume":"9","author":"Zadro","year":"2025","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.revmed.2026.04.003_bib0360","doi-asserted-by":"crossref","first-page":"e18739","DOI":"10.1097\/MD.0000000000018739","article-title":"Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.revmed.2026.04.003_bib0365","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1016\/j.transci.2023.103769","article-title":"Immunohematological evaluation of red cell alloimmunization and statistical assessment of various adsorption techniques in warm autoimmune hemolytic anemia","volume":"62","author":"Sekhar Das","year":"2023","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.13753","article-title":"Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization","volume":"295","author":"Versino","year":"2024","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0375","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/hematology.2022000406","article-title":"Evaluating patients with autoimmune hemolytic anemia in the transfusion service and immunohematology reference laboratory: pretransfusion testing challenges and best transfusion-management strategies","volume":"2022","author":"Johnson","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.revmed.2026.04.003_bib0380","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Transfusion de globules rouges homologues: produits, indications alternatives. Novembre 2014. https:\/\/www.has-sante.fr\/plugins\/ModuleXitiKLEE\/types\/FileDocument\/doXiti.jsp?id=c_2016518."},{"issue":"2","key":"10.1016\/j.revmed.2026.04.003_bib0385","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3324\/haematol.2020.250522","article-title":"Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study","volume":"106","author":"Fattizzo","year":"2021","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.revmed.2026.04.003_bib0390","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1182\/bloodadvances.2023011798","article-title":"Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis","volume":"8","author":"Fattizzo","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.revmed.2026.04.003_bib0395","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ajh.24047","article-title":"Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias","volume":"90","author":"Fattizzo","year":"2015","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0400","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jca.20096","article-title":"Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: a retrospective case-control study","volume":"21","author":"Ruivard","year":"2006","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0405","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13054-025-05601-6","article-title":"Severe autoimmune hemolytic anemia in ICU: a place for emergency plasma exchange? A French multicenter retrospective study. AIHA study group of the clinical data warehouse of Greater Paris University Hospitals","volume":"29","author":"Destival","year":"2025","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.revmed.2026.04.003_bib0410","doi-asserted-by":"crossref","first-page":"E371","DOI":"10.1002\/ajh.26665","article-title":"Characteristics and outcome of adults with severe autoimmune hemolytic anemia admitted to the intensive care unit: Results from a large French observational study","volume":"97","author":"Pouchelon","year":"2022","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.revmed.2026.04.003_bib0415","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830440404","article-title":"Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients","volume":"44","author":"Flores","year":"1993","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.revmed.2026.04.003_bib0420","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/ajh.27361","article-title":"Intravenous immunoglobulin as a rescue therapy for severe adult\u2019 autoimmune haemolytic anemia: results from a French multicentre observational study","volume":"99","author":"Michel","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2026.04.003_bib0425","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1016\/j.bcmd.2021.102621","article-title":"Systemic corticosteroids in the treatment of warm autoimmune hemolytic anemia: A clinical setting perspective","volume":"92","author":"Abdallah","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.revmed.2026.04.003_bib0430","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.1997.3203137.x","article-title":"Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type","volume":"98","author":"Meyer","year":"1997","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.24570","article-title":"A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)","volume":"92","author":"Michel","year":"2017","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0440","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.12541","article-title":"A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia","volume":"163","author":"Birgens","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0445","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2141.2002.03430.x","article-title":"Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura","volume":"117","author":"Howard","year":"2002","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.revmed.2026.04.003_bib0450","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2141.1996.4871026.x","article-title":"Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders","volume":"93","author":"Emilia","year":"1996","journal-title":"Br J Haematoly"},{"issue":"8","key":"10.1016\/j.revmed.2026.04.003_bib0455","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00277-023-05340-0","article-title":"Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing\/refractory multi-lineage autoimmune cytopenia","volume":"102","author":"Sorin","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.revmed.2026.04.003_bib0460","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2002-01-0087","article-title":"High-dose cyclophosphamide for refractory autoimmune hemolytic anemia","volume":"100","author":"Moyo","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.revmed.2026.04.003_bib0465","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.amjsurg.2012.05.030","article-title":"Outcomes and complications after splenectomy for hematologic disorders","volume":"204","author":"Patel","year":"2012","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0470","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bjh.16009","article-title":"Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia","volume":"187","author":"Fadlallah","year":"2019","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.revmed.2026.04.003_bib0475","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3324\/haematol.2021.279232","article-title":"Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia","volume":"106","author":"Crickx","year":"2021","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.revmed.2026.04.003_bib0480","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/09612033231163745","article-title":"Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort..","volume":"32","author":"Gonz\u00e1lez","year":"2023","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0485","doi-asserted-by":"crossref","first-page":"102913","DOI":"10.1016\/j.autrev.2021.102913","article-title":"Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"21","author":"Bernardoff","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0490","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/annrheumdis-2020-218886","article-title":"Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study","volume":"80","author":"Mo","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0495","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.24999","article-title":"Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults","volume":"93","author":"Serris","year":"2018","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.revmed.2026.04.003_bib0500","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-018-3979-4","article-title":"Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis","volume":"37","author":"Barron","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2026.04.003_bib0505","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1111\/trf.17141","article-title":"Splenectomy outcomes in patients with autoimmune cytopenias and persistent antiphospholipid antibodies","volume":"62","author":"Rangel-Pati\u00f1o","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0510","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","article-title":"Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)","volume":"25","author":"Wang","year":"2005","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.revmed.2026.04.003_bib0515","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.revmed.2026.04.003_bib0520","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/ajh.27754","article-title":"Durable responses with front-line rituximab in autoimmune cytopenias associated with indolent B-cell clones","volume":"100","author":"Zadro","year":"2025","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.revmed.2026.04.003_bib0525","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/leu.2015.273","article-title":"Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia","volume":"30","author":"Rogers","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.revmed.2026.04.003_bib0530","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajh.23909","article-title":"Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC\/MW and GOELAMS)","volume":"90","author":"Quinquenel","year":"2015","journal-title":"Am J Hematol"},{"issue":"16","key":"10.1016\/j.revmed.2026.04.003_bib0535","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood.2022018890","article-title":"Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience","volume":"141","author":"Fattizzo","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.revmed.2026.04.003_bib0540","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ajh.27339","article-title":"Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome","volume":"99","author":"Pla\u00e7ais","year":"2024","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.revmed.2026.04.003_bib0545","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2352-3026(18)30175-3","article-title":"Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study","volume":"6","author":"Delanoy","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.revmed.2026.04.003_bib0550","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejca.2019.07.014","article-title":"Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?","volume":"122","author":"Michot","year":"2019","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.revmed.2026.04.003_bib0555","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ajh.70010","article-title":"Cold agglutinin syndrome secondary to Mycoplasma pneumoniae infection in adults: results from a large French observational study (MyCOLD Study)","volume":"100","author":"Chevalier","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2026.04.003_bib0560","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.revmed.2026.04.003_bib0565","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood-2003-10-3597","article-title":"Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients","volume":"103","author":"Berentsen","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2026.04.003_bib0570","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2017-04-778175","article-title":"Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial","volume":"130","author":"Berentsen","year":"2017","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.revmed.2026.04.003_bib0575","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.2021012039","article-title":"Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease\/cold agglutinin syndrome","volume":"138","author":"Jalink","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2026.04.003_bib0580","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood-2018-03-835413","article-title":"Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study","volume":"132","author":"Rossi","year":"2018","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.revmed.2026.04.003_bib0585","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/bloodadvances.2018024190","article-title":"Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial","volume":"2","author":"R\u00f6th","year":"2018","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.revmed.2026.04.003_bib0590","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMoa2027760","article-title":"Sutimlimab in cold agglutinin disease","volume":"384","author":"R\u00f6th","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.04.003_bib0595","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood.2021014955","article-title":"Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial","volume":"140","author":"R\u00f6th","year":"2022","journal-title":"Blood"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632600531X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632600531X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:50:15Z","timestamp":1782921015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886632600531X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S024886632600531X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.04.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French protocol for the diagnosis and management of autoimmune hemolytic anemia in adults","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}